دورية أكاديمية
أعرض في EDS

A Motion-based Device Urinary Incontinence Treatment: A Longitudinal Analysis at 18 and 24 Months.

التفاصيل البيبلوغرافية
العنوان: A Motion-based Device Urinary Incontinence Treatment: A Longitudinal Analysis at 18 and 24 Months.
المؤلفون: Weinstein MM; Department of Obstetrics, Gynecology and Reproductive Biology, Division of Female Pelvic Medicine and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. mweinstein2@mgh.harvard.edu., Dunivan GC; University of Alabama at Birmingham, Birmingham, AL, USA., Guaderrama NM; Southern California Permanente Medical Group, Irvine, CA, USA., Richter HE; University of Alabama at Birmingham, Birmingham, AL, USA.
المصدر: International urogynecology journal [Int Urogynecol J] 2024 Apr; Vol. 35 (4), pp. 803-810. Date of Electronic Publication: 2024 Jan 22.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: England NLM ID: 101567041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-3023 (Electronic) Linking ISSN: 09373462 NLM ISO Abbreviation: Int Urogynecol J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Springer
مواضيع طبية MeSH: Exercise Therapy*/methods , Exercise Therapy*/instrumentation , Pelvic Floor*/physiopathology , Urinary Incontinence*/therapy, Adult ; Aged ; Female ; Humans ; Middle Aged ; Longitudinal Studies ; Time Factors ; Treatment Outcome ; Urinary Incontinence, Stress/therapy ; Follow-Up Studies
مستخلص: Introduction and Hypothesis: There are sparse data regarding the long-term efficacy of pelvic floor muscle training (PFMT) for the treatment of urinary incontinence (UI). The objective of this study was to evaluate the impact of an 8-week PFMT program guided by a motion-based intravaginal device versus a standard home program over 24 months.
Methods: Between October 2020 and March 2021, a total of 363 women with stress or stress-predominant mixed UI were randomized and completed an 8-week PFMT program using a motion-based intravaginal device (intervention group) or a home program following written/video instructions (control group). Participants were not asked to continue training after the 8-week program. At 18 and 24 months' follow-up, the Urogenital Distress Inventory, short-form (UDI-6) and Patient Global Impression of Improvement (PGI-I) were collected. In the original trial, a total of 139 participants in each arm were needed to detect a 0.3 effect size (alpha = 0.05, power 0.8, one-tailed t test) in the difference in UDI-6 scores.
Results: A total of 231 participants returned 24-month data. Mean age at 24 months was 51.7 ± 14.5 years, and mean BMI was 31.8 ± 7.4 kg/m 2 . Mean change in UDI-6 scores from baseline to 24 months was greater in the intervention group than the control group (-21.1 ± 24.5 vs -14.8 ± 19.4, p = 0.04). Reported improvement using PGI-I was greater in the intervention group than in the control group at 24 months (35% vs 22%, p = 0.03, OR 1.95(95% CI 1.08, 3.57).
Conclusions: Pelvic floor muscle training guided by a motion-based prescription intravaginal device yielded durable and significantly greater UI symptom improvement than a standard home program, even in the absence of continued therapy.
(© 2024. The Author(s).)
References: Cochrane Database Syst Rev. 2018 Oct 04;10:CD005654. (PMID: 30288727)
Int Urogynecol J. 2021 Feb;32(2):249-259. (PMID: 33175229)
Int Urogynecol J. 2020 Jun;31(6):1163-1174. (PMID: 31267139)
Female Pelvic Med Reconstr Surg. 2022 Jan 1;28(1):33-39. (PMID: 34009829)
Obstet Gynecol. 2022 Aug 1;140(2):275-292. (PMID: 35852280)
Neurourol Urodyn. 2022 Sep;41(7):1553-1562. (PMID: 35708134)
J Womens Health (Larchmt). 2018 Sep;27(9):1097-1103. (PMID: 29902123)
Med Sci Sports Exerc. 2011 Jul;43(7):1177-87. (PMID: 21131862)
Sports Med. 2006;36(2):133-49. (PMID: 16464122)
Neurourol Urodyn. 2015 Sep;34(7):600-5. (PMID: 25998603)
Am J Obstet Gynecol. 2001 Dec;185(6):1388-95. (PMID: 11744914)
Obstet Gynecol. 2023 Jan 1;141(1):199-206. (PMID: 36701620)
J Urol. 2018 Oct;200(4):848-855. (PMID: 29730202)
Am J Obstet Gynecol. 2005 Jul;193(1):103-13. (PMID: 16021067)
Neurourol Urodyn. 2020 Feb;39(2):863-870. (PMID: 31845393)
Neurourol Urodyn. 2022 Sep;41(7):1601-1611. (PMID: 35842824)
Neurourol Urodyn. 2022 Aug;41(6):1489-1497. (PMID: 35731185)
Neurourol Urodyn. 2013 Mar;32(3):215-23. (PMID: 22847318)
Curr Urol Rep. 2016 Feb;17(2):10. (PMID: 26757904)
J Gynecol Obstet Hum Reprod. 2020 Oct;49(8):101842. (PMID: 32592767)
JBI Database System Rev Implement Rep. 2017 May;15(5):1350-1408. (PMID: 28498174)
Am J Obstet Gynecol. 2009 May;200(5):580.e1-7. (PMID: 19375574)
Int J Nurs Stud. 2011 Oct;48(10):1165-72. (PMID: 21459381)
Sports Med. 2007;37(2):145-68. (PMID: 17241104)
Obstet Gynecol. 2022 Apr 1;139(4):606-615. (PMID: 35271539)
Neurourol Urodyn. 2017 Jan;36(1):132-135. (PMID: 26397715)
Female Pelvic Med Reconstr Surg. 2022 Apr 1;28(4):181-187. (PMID: 35030139)
Menopause. 2018 Jan;25(1):29-37. (PMID: 28763399)
Contemp Clin Trials. 2021 Jun;105:106406. (PMID: 33866003)
فهرسة مساهمة: Keywords: Conservative treatment; Motion-based biofeedback; Urinary incontinence
تواريخ الأحداث: Date Created: 20240122 Date Completed: 20240426 Latest Revision: 20240529
رمز التحديث: 20240529
مُعرف محوري في PubMed: PMC11052829
DOI: 10.1007/s00192-023-05721-z
PMID: 38252280
قاعدة البيانات: MEDLINE
الوصف
تدمد:1433-3023
DOI:10.1007/s00192-023-05721-z